Phase 2Status unknown

A Study to Test a New Multi-Analyte Sensor During Meal Tests

Feasibility Study of a Multi-Analyte Sensor for Metabolic Monitoring During Meal Tests

Sponsor
St Vincent's Hospital Melbourne
Enrolment
20 planned
Conditions
Diabetes mellitus; Metabolic and Endocrine - Diabetes
Interventions
All eligible participants will be transferred to the investigational device, the PercuSense Atlas Health Multi-Analyte Sensor (MAS); Abbott Libre 2 Plus) will also be inserted according to participant preference into the abdomen, thigh or in the back postero-laterally just above the beltline
Ages
adults, older adults
Registry
ACTRN12626000965303

Full record on ANZCTRSource: WHO ICTRP, processed 10 August 2026

Primary outcomes

  • Duration of sensor function (hours) according to insertion site.[PercuSense Atlas Health Multi-Analyte Sensor From time of device insertion until end of study]
  • The number of failed insertions [Study database records From time of device insertion until end of study]
  • The number of sensor failures[PercuSense Atlas Health Multi-Analyte Sensor Data From time of device insertion until end of study]

History

  1. Started

  2. Last registry update

  3. Registered